The Philippines became the first Asian country on Tuesday to approve the sale of the world's first-ever dengue vaccine.
Dengvaxia, manufactured by French pharmaceutical giant Sanofi, secured its first regulatory approval in Mexico a fortnight ago and is currently being reviewed by around 20 countries in Asia and Latin America.
It is hoped the drug could eventually help prevent millions of deaths from dengue, the world's fastest-growing mosquito-borne disease.
The World Health Organisation says as many as 400 million people are infected worldwide every year, and two-thirds are in Asia. "It's a major step in the prevention of dengue and for public health," Olivier Charmeil, head of Sanofi's vaccines division, said in a statement.
Scientists have long been stumped by dengue, which has four separate strains, forcing researchers to find a drug able to fight all of them at once.
Clinical tests – carried out on 40,000 people from 15 countries – have found Dengvaxia can immunise two-thirds of people aged nine years and older, rising to 93 per cent for the more severe form of the disease, dengue haemorrhagic fever. It was also found to reduce the risk of hospitalisation by 80 per cent.
Dengue can trigger a crippling fever, along with muscle and joint pain. There is no known cure, and children are at particular risk. The deadliest form of the disease kills 22,000 people a year, the WHO says.
It was once considered a disease of the tropics, endemic in only nine countries, but globalisation, urbanisation, climate change and jet travel are helping it to move into more temperate zones. It is now endemic in more than 100 countries.
The WHO says cases have risen 30-fold over the last 50 years, with more than half the world's population potentially at risk. Several million doses of the vaccine are ready to ship, and Sanofi expects annual production to reach 100 million doses by 2017.
Sanofi's research and development work took 20 years, costing more than €1.5 billion (US$1.6 billion). But the vaccine could bring the company more than US$1 billion annually starting in 2018 or 2019, analysts said.
Other pharmaceutical companies are developing dengue vaccines, including US firm Merck, Japan's Takeda and Britain's GlaxoSmithKline, but Sanofi is ahead of the competition.
AFP
Wed Dec 23 2015
A 2011 file photo of employees working in Sanofi-Pasteur, the vaccine branch of French pharmaceutical giant Sanofi-Aventis in Marcy-l'Etoile, outside Lyon. Sanofi's research and development work in developing the vaccine took 20 years. - AFP Photo
Proses penamaan calon berlangsung 9 pagi ini
Pilihan Raya Kecil (PRK) Dewan Undangan Negeri (DUN) Kuala Kubu Baharu (KKB) membuka tirai hari ini dengan bermulanya proses penamaan calon di Dewan Serbaguna Dan Kompleks Sukan Daerah Hulu Selangor.
Penunggang motosikal berkuasa tinggi maut nahas
Mangsa lelaki berusia 34 tahun yang bekerja sebagai pemuzik di DBKL meninggal dunia di tempat kejadian.
Bebaskan pasaran buruh dari perangkap gaji berasaskan kelayakan akademik - Penganalisis
Malaysia harus beralih ke arah penetapan gaji berdasarkan kompetensi pekerja.
Raja Charles III sambung tugas awam minggu depan
Raja Britain, Raja Charles ketiga akan meneruskan tugas awamnya minggu depan setelah cataT perubahan baik dalam rawatan kanser. Baginda akan memulakan dengan lawatan simbolik ke pusat rawatan kanser.
Demonstrasi pro-Palestin di kampus universiti AS
Demonstrasi pro-Palestin tercetus di beberapa kampus utama Amerika Syarikat. Pelajar menuntut gencatan senjata kekal dan menekan Washington untuk menamatkan sumbangan dana tentera kepada Israel.
Dakwaan Israel: PBB masih siasat 8 individu
Pasukan Khas PBB menutup satu kes dan menggantung tiga kes berhubung dakwaan terhadap 12 petugas UNRWA yang terlibat dengan Hamas, susulan kekurangan bukti dari Israel.
Hamas mahu gencatan senjata bersyarat
Hamas komited kuatkuasa gencatan senjata dalam perang dengan Israel, namun dengan syarat yang dituntut.
Penghidap kanser tulang impikan telefon bimbit
Siti Zubaidah, calon SPM yang mengidap kanser tulang, bercita-cita memiliki telefon bimbit untuk merakam kenangan sebelum pergi. Petronas merealisasikan impian ini melalui program 50 Dreams.
Malaysia seru pihak terlibat supaya bertenang dan minta siasatan dijalankan terhadap isu kemanusiaan di Gaza
Malaysia seru semua pihak yang terlibat supaya bertenang dan menghentikan tindakan provokatif yang boleh memburukkan lagi konflik di rantau Asia Barat.
PRK Kuala Kubu Baharu bermula hari ini
PRK DUN Kuala Kubu Baharu dimulakan hari ini dengan proses penamaan calon di Dewan Serbaguna dan Kompleks Sukan Daerah Hulu Selangor. Calon dari parti serta calon bebas boleh serahkan borang pencalonan mulai jam 9 pagi.
Awas! Empat krisis dunia ini dikhuatiri jadi lebih buruk akibat COVID-19
Selain menyebabkan kematian dan kerugian besar kepada ekonomi, ia juga boleh menyebabkan krisis berkaitan kemanusiaan menjadi bertambah buruk.
Climate change in Malaysia and what it means for us
The worlds climate is changing for the worse, and humans are responsible for that. Lets dive into a touch of science to make sense of this.
Demam denggi menurun kepada 1,300 kes minggu lepas - Subramaniam
Penurunan sebanyak 1,200 kes itu berikutan pelbagai usaha Kementerian Kesihatan dalam mengawal pembiakan nyamuk Aedes terutama di kawasan berisiko.
CukupSetakatSamson: Isteri Allahyarham pesan agar masyarakat tidak leka
Zamila Razeman, 27, turut mengingatkan masyarakat supaya tidak mengambil mudah kerana demam panas melampau termasuk dalam simptom denggi yang boleh membawa maut.